Latest Content

Dr. Catherine A. Shu highlights targeted therapies for patients with lung cancer, emphasizing advances, challenges and the importance of clinical trials.

Many fail to recognize that estrogen is necessary to help your body and its parts work in concert with each other seamlessly.  

The FDA has granted fast track designation to ITM-94 as a diagnostic agent for the detection of the most common type of kidney cancer.

The FDA has approved Epkinly plus Revlimid and Rituxan for the treatment of patients with relapsed or refractory follicular lymphoma.

Steve Brown and Lisa Booth explain how AI platforms like CureWise offer clarity, reduce anxiety, and support informed decisions during the cancer journey.

I am thankful that a nurse navigator gave me continuity of compassionate care that helped me to heal from the inside out.

Young adults with newly diagnosed cancer may feel overwhelmed, but open communication with doctors and support groups can help them feel less alone.

Todd Kennedy, a multiple myeloma survivor, explains how switching from an hours-long IV infusion to a 3-minute Sub-Q injection changed his life.

A man nearing 76 reflects on aging, family, loss and living with cancer while finding gratitude in the holiday season.

Patients with severe pancreatic cancer pain experienced consistent improvements in functionality and quality of life following targeted ablation therapy.

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

Learn about stage 2 vaginal cancer, including symptoms, diagnosis, treatment options, side effects and questions to discuss with your care team.

Stage 2 multiple myeloma can feel overwhelming. Learn what it means, treatment options, and key questions to discuss with your oncologist.